318 related articles for article (PubMed ID: 18679037)
1. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence?
Thomas W; Speer CP
Neonatology; 2008; 94(3):150-9. PubMed ID: 18679037
[TBL] [Abstract][Full Text] [Related]
2. Prevention and therapy of bronchopulmonary dysplasia - evidence and clinical practice.
Thomas W; Speer CP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):264-77. PubMed ID: 17582275
[TBL] [Abstract][Full Text] [Related]
3. [From classic to new bronchopulmonary dysplasia].
Kramer BW; Lievense S; Been JV; Zimmermann LJ
Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
5. Progress in discovery and evaluation of treatments to prevent bronchopulmonary dysplasia.
Van Marter LJ
Biol Neonate; 2006; 89(4):303-12. PubMed ID: 16770070
[TBL] [Abstract][Full Text] [Related]
6. Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models.
Rieger-Fackeldey E; Hentschel R
J Perinat Med; 2008; 36(5):442-7. PubMed ID: 18605970
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
Schmidt B; Roberts R; Millar D; Kirpalani H
Neonatology; 2008; 93(4):284-7. PubMed ID: 18525211
[TBL] [Abstract][Full Text] [Related]
8. Bronchopulmonary dysplasia.
Deakins KM
Respir Care; 2009 Sep; 54(9):1252-62. PubMed ID: 19712501
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological prophylaxis and treatment of bronchopulmonary dysplasia].
Groneck P; Speer CP
Z Geburtshilfe Neonatol; 2005 Aug; 209(4):119-27. PubMed ID: 16138269
[TBL] [Abstract][Full Text] [Related]
10. Drug therapies in bronchopulmonary dysplasia: debunking the myths.
Tin W; Wiswell TE
Semin Fetal Neonatal Med; 2009 Dec; 14(6):383-90. PubMed ID: 19747890
[TBL] [Abstract][Full Text] [Related]
11. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
Pantalitschka T; Poets CF
Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
[TBL] [Abstract][Full Text] [Related]
12. The 'new' bronchopulmonary dysplasia: challenges and commentary.
Merritt TA; Deming DD; Boynton BR
Semin Fetal Neonatal Med; 2009 Dec; 14(6):345-57. PubMed ID: 19747889
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of bronchopulmonary dysplasia.
Van Marter LJ
Semin Fetal Neonatal Med; 2009 Dec; 14(6):358-66. PubMed ID: 19783238
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive therapies in chronic lung disease: examining the evidence.
Tin W; Wiswell TE
Semin Fetal Neonatal Med; 2008 Feb; 13(1):44-52. PubMed ID: 17983879
[TBL] [Abstract][Full Text] [Related]
15. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia.
Ambalavanan N; Carlo WA
Semin Perinatol; 2006 Aug; 30(4):192-9. PubMed ID: 16860159
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia.
Baveja R; Christou H
Semin Perinatol; 2006 Aug; 30(4):209-18. PubMed ID: 16860161
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for the Prevention of Bronchopulmonary Dysplasia: Can Anything Compete with Caffeine and Corticosteroids?
McPherson C
Neonatal Netw; 2019 Jul; 38(4):242-249. PubMed ID: 31470395
[TBL] [Abstract][Full Text] [Related]
18. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of bronchopulmonary dysplasia.
Hayes D; Feola DJ; Murphy BS; Shook LA; Ballard HO
Respiration; 2010; 79(5):425-36. PubMed ID: 19786727
[TBL] [Abstract][Full Text] [Related]
20. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
